David McClung
2022
In 2022, David McClung earned a total compensation of $565.1K as Chief Financial Officer at Tiger X Medical, a 15% decrease compared to previous year.
Compensation breakdown
| Option Awards | $78,743 |
|---|---|
| Salary | $382,000 |
| Stock Awards | $104,361 |
| Total | $565,104 |
McClung received $382K in salary, accounting for 68% of the total pay in 2022.
McClung also received $78.7K in option awards and $104.4K in stock awards.
Rankings
In 2022, David McClung's compensation ranked 4,076th out of 5,542 executives tracked by ExecPay. In other words, McClung earned more than 26.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,076 out of 5,542 | 27th |
Division Manufacturing | 2,293 out of 3,000 | 24th |
Major group Chemicals And Allied Products | 1,106 out of 1,350 | 18th |
Industry group Drugs | 1,036 out of 1,253 | 17th |
Industry Biological Products, Except Diagnostic Substances | 249 out of 287 | 13th |
Source: SEC filing on September 1, 2023.
McClung's colleagues
We found two more compensation records of executives who worked with David McClung at Tiger X Medical in 2022.
News
Tiger X Medical CEO Peter Altman's 2023 pay slips 17% to $746K
April 15, 2024
Tiger X Medical CEO Peter Altman's 2022 pay falls 21% to $902K
September 1, 2023
Tiger X Medical CEO Peter Altman's 2021 pay jumps 29% to $1.1M
April 27, 2022
Tiger X Medical CEO Peter Altman's 2019 pay falls 39% to $678K
December 1, 2020
Tiger X Medical CEO Peter Altman's 2018 pay jumps 196% to $1.1M
October 15, 2019